Mironova Labs

Actives for Lash & Brow Serums

Non-PG hair growth actives and cosmetic peptides for regulated lash & brow markets

For lash/brow serum brands navigating prostaglandin regulation and evaluating alternative active ingredients

Supported by peer-reviewed researchUS-manufacturedMulti-analog PG supplyNon-PG alternatives availableRegulatory-aware

Your Challenge. Our Answer.

We understand the specific problems you face — and we built solutions for each one.

The Problem

EU SCCS and Health Canada have flagged or restricted prostaglandin analogues in cosmetics, creating regulatory uncertainty for lash/brow serums

Mironova’s Answer

Mironova offers both prostaglandin analogs (for markets where permitted) and non-PG alternatives — so your brand can adapt to any regulatory environment

The Problem

Single-source prostaglandin supply creates business risk if that supplier faces quality or regulatory issues

Mironova’s Answer

Mironova manufactures multiple PG analogs in-house, providing supply diversification with consistent quality from one US facility

The Problem

Consumer awareness of prostaglandin side effects (periorbital fat loss, iris darkening) is driving demand for PG-free alternatives

Mironova’s Answer

Our non-PG hair growth actives (Kopyrrol Aqua, Kopexil Aqua) and cosmetic peptides offer alternative mechanisms without PG-associated concerns

Published Evidence

Key findings from peer-reviewed literature relevant to your application.

EU Regulatory Landscape

SCCS concludes that prostaglandin analogues MDN, isopropyl cloprostenate, and DDDE cannot be considered safe in cosmetic products for eyelash/eyebrow growth.

EU SCCS Opinion SCCS/1680/25

Canada PG Prohibition

Prostaglandins, their salts, derivatives and analogues are listed as prohibited in cosmetic products in Canada.

Health Canada Cosmetic Ingredient Hotlist

Non-PG Mechanism: Collagen Modulation

DPO (aminexil) modulates lysyl hydroxylase mRNA expression, targeting the collagen maturation pathway — a mechanistically distinct approach from prostaglandins.

Mahé et al., Skin Pharmacology 1996

Lash/Brow Serum Formulation Notes

  • Diaminopyrimidine actives: 0.2–1.5% (w/w); cosmetic peptides: 1–50 ppm
  • Water-soluble actives — no organic co-solvents needed for periorbital application
  • Myristoyl lipopeptides pair well in multi-target lash serums (keratin + growth phase support)
  • Compatible with common serum bases (HA, glycerin, panthenol)
  • pH stability range: 4.5–7.0 for peptide-containing formulations
  • Contact Mironova for prostaglandin analog availability in your market

Request Technical Data

Get product specifications, CoA samples, and pricing for your evaluation.

We respond within one business day. No spam, ever.

Discuss Your Formulation Needs

Our team can help navigate the PG regulatory landscape and recommend the right active strategy for your market and brand positioning.

Or call us at +1 (973) 244-0393

Related Resources

Technical data, product specifications, and application guidance.